文献速递泌尿系结石

人输尿管自然扩张性的临床测定:初步研究

Clinical determination of the natural distensibility of the human ureter: initial study.
PubMed 文献 · BJU Int · 2024-10-26

本研究纳入101例接受输尿管镜碎石取石术或经皮肾镜取石术的患者,用连接力传感器的37 cm尿道扩张器以2 F递增顺序测量输尿管尺寸,插入力限制为6 N。结果显示61%患者可通过≤14 F扩张器,39%可接受≥16 F;术前输尿管支架置入和抗生素使用与通过16 F扩张器相关,而坦索罗辛和既往尿路感染无影响。

要点

  • 在6 N插入力阈值下,多数无支架成人输尿管可安全容纳14 F扩张器。
  • 术前存在输尿管支架或一周内使用抗生素者更可能安全通过16 F扩张器。
  • 坦索罗辛使用和既往尿路感染对输尿管尺寸无显著影响。

核心结论

  • 使用连续插入力监测和6 N阈值,本患者群体中大多数无支架成人输尿管可安全容纳14 F扩张器。
  • 在6 N阈值下安全通过16 F扩张器在术前存在输尿管支架或术前一周内接受抗生素治疗的患者中更可能。

研究设计与样本

  • 共101例接受输尿管镜碎石取石术或经皮肾镜取石术的患者,使用连接独特力传感器的37 cm尿道扩张器以2 F递增顺序进行输尿管尺寸测量。
  • 插入力限制为6 N,达到6 N后置入合适尺寸的输尿管通道鞘,每例手术结束时测定输尿管镜术后损伤量表评分。

主要发现

  • 61%的患者可通过≤14 F尿道扩张器,39%的患者接受≥16 F尿道扩张器,平均扩张器尺寸为14 F。
  • 多因素logistic回归分析显示,术前输尿管支架置入与通过16 F扩张器相关(OR 5.16,95%CI 1.70-15.62,P=0.004),抗生素使用也与通过16 F扩张器相关(OR 5.15,95%CI 1.743-15.243,P=0.003)。
  • 坦索罗辛对输尿管尺寸无影响(OR 0.765,95%CI 0.281-2.084,P=0.601),既往尿路感染对输尿管尺寸无影响(OR 1.049,95%CI 0.269-4.089,P=0.945)。

关键数值与推荐

  • 插入力阈值设定为6 N。
  • 尿道扩张器以2 F递增,长度为37 cm。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To define the natural distensibility of the human ureter and evaluate the impact of other possibly favourable factors on ureteric distensibility. PATIENTS AND METHODS: A total of 101 patients undergoing ureteroscopic stone removal or percutaneous nephrolithotomy underwent ureteric sizing using sequential passage of 37-cm urethral dilators in 2-F increments while attached to a unique force sensor. Insertion forces were limited to 6 N. After 6 N was attained, an appropriately sized ureteric access sheath was passed. At the conclusion of each procedure, Post-Ureteroscopic Lesion Scale score was determined. RESULTS: Urethral dilators were passed in 61% of patients at ≤14 F; 39% of patients accepted urethral dilators of ≥16 F. The mean dilator size was 14 F. Multivariate logistic regression analysis revealed that preprocedural ureteric stenting and antibiotic use favoured passage of 16-F dilators (odds ratio [OR] 5.16, 95% confidence interval [CI] 1.70-15.62 [P = 0.004] and OR 5.15, 95% CI 1.743-15.243 [P = 0.003], respectively). Neither tamsulosin nor prior urinary tract infection had an impact on ureteric size (OR 0.765, 95% CI 0.281-2.084 [P = 0.601], OR 1.049, 95% CI 0.269-4.089 [P = 0.945], respectively). CONCLUSION: Using continuous insertion force monitoring and a 6-N threshold, the majority of unstented adult human ureters within our patient population safely accommodated a 14-F dilator. Safe passage of a 16-F dilator at the 6-N threshold was more likely among patients with a preexisting indwelling ureteric stent or patients who were treated with antibiotics within a week of the procedure.

来源:BJU Int,查看原文。版权归原作者所有。

引用

  1. Ali SN, McCormac A, Cumpanas AD, et al. Clinical determination of the natural distensibility of the human ureter: initial study. BJU Int. 2024. PMID: 39460553. doi:10.1111/bju.16564

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。